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Pseudomonas and Bacillus Soil Isolates Produce Antibiotics
Chelsea Brandt and Dr. Lori Scott
INTRODUCTION
Antibiotics have been a prominent tool for treating infection for
nearly 100 years, but the recent emergence of antibiotic resistant
strains of bacteria have prompted scientific inquiry into new
methods of fighting infection [8]. With the list of effective
medications diminishing and the limited discovery of new
antibiotics, antibiotic resistance poses a significant threat to
human survival [8]. Of particular importance to the discussion of
antibiotic resistance are the ESKAPE pathogens: Enterococcus
faecium, Staphylococcus aureus, Klebsiella pneumoniae,
Acinetobacter baumannii, Pseudomonas aeruginosa, and
Enterobacter spp. These pathogens cause 15.5% of nosocomial
infections worldwide, are associated with high risks of mortality,
and are becoming increasingly resistant to existing medications,
making them one of the most important groups of bacteria to
study [2, 6, 9, 10]. While studies of combinations of antibiotics,
bacteriophage therapy, antimicrobial peptides, photodynamic light
therapy, and silver nanoparticles show potential, the discovery of
new antibiotics remains crucial for combating antibiotic
resistance [8]. The Tiny Earth Project Initiative (TEPI) is one
such global, student oriented research project that confronts the
antibiotic resistance crisis by searching for new antibiotics in soil
samples [5].

METHODS
Unless described otherwise, the bacterial strains and protocols used
in this study were provided by the Tiny Earth Project Initiative
(TEPI) [5].
• Soil samples were collected from Duck Creek Park in Davenport,
IA on January 9, 2020.
• Using a slurry of the soil sample, serial dilutions were made and
then plated onto LB agar, 10% TSA, and PDA petri dishes and
cultured at 28ºC for 48 hours.
• Bacteria colonies were streaked and cultured on master plates of
corresponding media.
• Bacteria from the master plates were streaked onto spread plates
of Bacillus subtilis and Escherichia coli to observe any zones of
inhibition.
• Colony PCR was run on confirmed antibiotic producers. DNA
from gel electrophoresis was extracted and analyzed by 16S
rRNA genetic sequencing at the Iowa Institute of Human
Genetics at the University of Iowa using the primers 27F and
1492R.
• NCBI BLAST was used to identify the genus of the antibiotic
producing soil isolates.

RESULTS
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FDA approvals of new antibiotics since the 1980s [4].

On a global level, TEPI aims to educate students and
professionals about the antibiotic crisis while amassing soil
bacteria data and isolating novel antibiotic producers [5]. This
poster details an experiment that contributes to TEPI by isolating
antibiotic producing bacteria in a local Iowa soil sample. Soil
bacterial isolates are tested against known tester strains Bacillus
subtilis and Escherichia coli. B. subtilis is a fast growing, Gram
positive, rod shaped bacteria typically found in soil, water, and
around plants [7]. It is extensively studied and valued for its
protein production abilities [7]. E. coli is a fast growing, Gram
negative, rod shaped bacteria typically found in the
gastrointestinal tract of humans and animals. Most strains of E.
coli are harmless, but some strains have acquired pathogenicity
and are a common foodborne pathogen [11]. By testing unknown
soil isolates against B. subtilis and E. coli, student researchers
eliminate the risk of exposure to the dangerous antibiotic resistant
ESKAPE strains while still permitting inquiry into new methods
of treatment. With antibiotic resistance spreading so quickly
between bacterial species, the human population is in dire need of
research into new antibiotics. By contributing to TEPI, this
project increases the range of potential antibiotic producing
bacteria and promotes further research into novel antibiotics to
combat antibiotic resistance.

Figure 2. Soil isolates CB-7TSA, CB-7-LB, and CB-11LB are confirmed to produce
antibiotics. Each of these
isolates exhibit a zone of
inhibition (ZOI) against B.
subtilis. Only CB-7-LB
exhibits a ZOI against E.
coli. CB-7-LB and CB-7TSA show the largest ZOIs
so these two isolates were
chosen to undergo further
genetic testing for
identification.
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Figure 4. NCBI BLAST results show that CB-7-LB is of the genus
is Bacillus and CB-7-TSA is of the genus Pseudomonas [3]. Query
coverage indicates the percentage of the gene that was sequenced in
the database. The percent identity indicates the percentage of base
pairs from the experimental sample that are identical to the hit from
the database. The E value indicates the probability that the hits
would have been pulled out of the database at random. Both
samples show a query coverage at 99%, percent identity above 99%,
and E values at zero which indicates the validity of these results.
For both samples, the genus shows no variability in the top ten hits
while the species varies without significant differences in the
statistical values. Therefore, the identity of the genus can be
confirmed while the species cannot be and it is concluded that CB7-LB is Bacillus and CB-7-TSA is Pseudomonas.

DISCUSSION
Antibiotic producing bacteria were isolated from an Iowa soil
sample and identified as Bacillus and Pseudomonas, which are both
consistent with common bacteria found in soil [1, 3]. Data from this
project was sent to TEPI to be recorded in the national database and
used for further research. In future studies, the bioactive molecule
produced by the samples should be identified and isolated using a
biological assay and chemical techniques for isolation and
purification [5]. The identity of the molecules should be compared
with known antibiotics to determine whether a novel antibiotic was
produced and can be developed into new antibiotics. Additionally,
CB-18-TSA should be taken through the processes of16S rRNA
gene sequencing and identification of bioactive molecules as it was
also a confirmed antibiotic producer.
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